Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yunnan Jinqi Pharmaceutical is a specialized pharmaceutical company based in Wenshan, China, the primary production hub for Panax notoginseng (Sanqi). The company focuses on the comprehensive research, development, and industrialization of Sanqi-based medicinal products, integrating GAP-certified cultivation with high-tech GMP manufacturing. Their primary product portfolio targets cardiovascular and cerebrovascular health, utilizing standardized extraction of notoginsenosides to produce oral liquids, granules, and capsules. Recognized as a National High-tech Enterprise, Yunnan Jinqi Pharmaceutical is a leader in modernizing Traditional Chinese Medicine through scientific validation and advanced processing technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yunnan Jinqi Pharmaceutical.